KIMBERLY ROBERTSON: Open Payments
NPI 1720461924 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 64 payments from 12 companies in 2025. Trend: 2023 $1,099 · 2024 $1,386 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $261 |
| ABBVIE INC. | 20 | $207 |
| PFIZER INC. | 20 | $184 |
| Exact Sciences Corporation | 5 | $86 |
| Novo Nordisk Inc | 5 | $79 |
| Amgen Inc. | 2 | $56 |
| Neurelis, Inc. | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 3 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: BREZTRI, NURTEC ODT, VRAYLAR, Cologuard Collection Kit, Wegovy, UBRELVY, UPLIZNA, VALTOCO.
Industry payments across IN — which companies pay providers there.
